ANVISA’s home brewed scaling? [RSABE / ABEL]

posted by ElMaestro  – Denmark, 2015-05-28 21:10 (3550 d 14:36 ago) – Posting: # 14878
Views: 9,811

Hi Helmut,

❝ […] in the cases that the intra-subject coefficient of variation (CV%) exceeds 40% for the originator product.


Haha, for a moment I thought you were serious. But then realised that of course no agency will be enforcing such a weird and unjustified requirement.

You almost had me there. Great sense of humour.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
80 visitors (0 registered, 80 guests [including 10 identified bots]).
Forum time: 10:46 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5